Skip to main content

Coronavirus Watch: Pfizer to seek vaccine approval 'within days'


More good news: Pfizer and its collaborator BioNTech announced early Wednesday they plan to start the Food and Drug Administration approval process "within days" for their candidate vaccine, after further analysis showed it is 95% effective.

The companies hope to provide 50 million doses by year's end and 1.3 billion doses in 2021.

And U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed and developed entirely at home. It's a 30-minute test kit from Lucira Health, a California manufacturer.

It's Wednesday, and this is the Coronavirus Watch from the Paste BN Network. Here's the most significant news of the day, as of 11:30 a.m. ET:

Check out our special publication, America Recovers, which pays tribute to those keeping America going amid the pandemic. The special edition is available at newsstands and online here.

Today's numbers: The U.S. has reported more than 11.3 million cases and 248,000 deaths. Globally, there have been 55.7 million cases and 1.3 million fatalities. See the numbers in your area here, and check out where cases are rising here.

Thank you for subscribing!

– Grace Hauck, Paste BN breaking news reporter, @grace_hauck